Brady James Aloysius
SEC insider (Form 3/4/5 filer). CIK 0001916987. Director at Xeris Biopharma Holdings, Inc. (XERS) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CHICAGO, IL.
Companies Brady James Aloysius has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Director
- Verona Pharma plc (VRNA): Director
Brady James Aloysius
CIK: 0001916987
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 4, 2026XERS
Xeris Biopharma Holdings, Inc.
AwardDirect24.2K shares- - Mar 30, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect10.8K shares at avg. $5.54$60K - Oct 7, 2025VRNA
Verona Pharma plc
ExerciseDirect72K shares- - Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect72K shares- - Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect23.2K shares- - Aug 1, 2025VRNA
Verona Pharma plc
SaleDirect824 shares at avg. $13.14$11K - Aug 1, 2025VRNA
Verona Pharma plc
ExerciseDirect24K shares- - Apr 25, 2025VRNA
Verona Pharma plc
AwardDirectRestricted Share Units
96K shares- - Mar 28, 2025XERS
Xeris Biopharma Holdings, Inc.
AwardDirect100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  XERS Xeris Biopharma Holdings, Inc. | Award | 24,193 | - | $0 | Direct |
| Mar 30, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 10,834 | $5.54 | $60,036 | Direct |
| Oct 7, 2025 |  VRNA Verona Pharma plc | Exercise | 72,000 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 72,000 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 23,176 | - | - | Direct |
| Aug 1, 2025 | VRNA Verona Pharma plc | Sale | 824 | $13.14 | $10,830 | Direct |
| Aug 1, 2025 | VRNA Verona Pharma plc | Exercise | 24,000 | - | - | Direct |
| Apr 25, 2025 | VRNA Verona Pharma plc | Award Restricted Share Units | 96,000 | - | - | Direct |
| Mar 28, 2025 | XERS Xeris Biopharma Holdings, Inc. | Award | 100,000 | - | - | Direct |
1-9 of 9 transactions